In vivo ≫ in vitro [Regulatives / Guidelines]

posted by Helmut Homepage – Vienna, Austria, 2015-09-17 14:41 (3931 d 05:11 ago) – Posting: # 15417
Views: 9,143

Merhaba Erkin,

❝ But I don't understand is: we made a bioequivalence study and we found the products as bioequivalent.


Fine. End of story.

❝ After that why we bother about ƒ2 unless sponsor wants to improve their product (and they need to do a new BE study afterall.)


I never bothered. IMHO, Appendix I 1.i is the most important part. It is highly unlikely that you ever find a dis­criminatory method for BCS classes II and IV (by definition). Even if you succeed, I would think that’s just a coincidence.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
145 visitors (0 registered, 145 guests [including 34 identified bots]).
Forum time: 19:52 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5